- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Dabrafenib; trametinib – March 2019
Dabrafenib and Trametinib: dabrafenib: Capsule 50 mg, Capsule 75 mg; trametinib: Tablet 500 microgra
Last updated
19 July 2019